Developing tiny technologies to understand blood-related health issues
Engineering biophysical microtechnologies for hematologic applications in health and disease
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11045002
This study is working on new tools to better understand how blood cells behave in both healthy and sick conditions, which could help improve treatments for blood disorders like autoimmune thrombocytopenias and sickle cell disease, making life easier for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11045002 on ClinicalTrials.gov |
What this research studies
This research focuses on creating advanced microtechnologies to study how blood cells interact in both healthy and diseased states. By combining expertise in clinical hematology and bioengineering, the team aims to develop tools that can mimic real-life blood processes, allowing for better understanding and treatment of conditions like autoimmune thrombocytopenias and sickle cell disease. Patients may benefit from these innovations as they could lead to more effective therapies and diagnostic methods tailored to their specific blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune thrombocytopenias or sickle cell disease.
Not a fit: Patients with unrelated hematological conditions or those not experiencing blood-related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and diagnostic tools for patients with blood-related diseases.
How similar studies have performed: Other research has shown promise in using microtechnologies for studying blood processes, indicating a potential for success in this innovative approach.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAM, WILBUR A — EMORY UNIVERSITY
- Study coordinator: LAM, WILBUR A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.